Efficacy and Safety of Intrathecal Pemetrexed + Dexamethasone for Treating TKI-Failed Leptomeningeal Metastases From EGFR-Mutant NSCLC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Efficacy and Safety of Intrathecal Pemetrexed Combined With Dexamethasone for Treating Tyrosine Kinase Inhibitor-Failed Leptomeningeal Metastases From EGFR-Mutant NSCLC—A Prospective, Open-Label, Single-Arm Phase 1/2 Clinical Trial
J Thorac Oncol 2021 Aug 01;16(8)1359-1368, C Fan, Q Zhao, L Li, W Shen, Y Du, C Teng, F Gao, X Song, Q Jiang, D Huang, Y Jin, Y Lv, L Wei, T Shi, X Zhao, N Gao, Z Jiang, T XinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.